Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature

Transfusion Medicine Reviews

Volumn 12, Issue 3, 1998, Pages 206-225

  Faught, C ^a   Wells, P ^a   Fergusson, D ^a   Laupacis, A ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; DESMOPRESSIN; HISTAMINE; RECOMBINANT ERYTHROPOIETIN; TRANEXAMIC ACID;

BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FATIGUE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERSENSITIVITY REACTION; HYPERTENSION; HYPONATREMIA; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MUSCLE NECROSIS; MYOGLOBINURIA; NAUSEA; ORAL DRUG ADMINISTRATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; REVIEW; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL PATIENT; THROMBOEMBOLISM; THROMBOSIS; VERTIGO; WATER INTOXICATION;

EID: 0031848714     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(98)80061-8     Document Type: Article

References (196)

1. Laupacis A Fergusson D for the International Study of Peri-Operative Transfusion (ISPOT) Investigators Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome Anesth Analg 85 1997 1258 1267
2. Bryson GL Laupacis A Wells GA for the International Study of Peri-Operative Transfusion (ISPOT) Investigators Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis Anesth Analg 86 1998 9 15
3. (in press) Forgie M Wells PS Laupacis A for the International Study of Peri-Operative Transfusion (ISPOT) Investigators Pre-operative autologous donation decreases allogeneic transfusion but increases exposure to all red cell transfusion Arch Intern Med 1998
4. 988 [computer program] Lau J & Chalmers TC 1995
5. Green D Wong CA Twardowski P Efficacy of hemostatic agents in improving surgical hemostasis Transfus Med Rev 10 1996 171 182
6. Royston D Coagulation in cardiac surgery Adv Cardiac Surg 8 1996 19 45
7. Robert S Wagner BK Boulanger M Aprotinin Ann Pharmacother 30 1996 372 380
8. Dietrich W Barankay A Hahnel C High-dose aprotinin in cardiac surgery: Three years' experience in 1,784 patients J Cardiothorac Vasc Anesth 6 1992 324 327
9. Bidstrup BP Harrison J Royston D Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United Kingdom Ann Thorac Surg 55 1993 971 976
10. Martinelli L Maurelli M Vigano M Aprotinin in staged heart transplantation: Anaphylactic potential of repeated exposure Ann Thorac Surg 61 1996 1288 1289
11. Diefenbach C Abel M Limpers B Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery Anesth Analg 80 1995 830 831
12. Dewachter P Mouton C Masson C Anaphylactic reaction to aprotinin during cardiac surgery Eur J Cardiothorac Surg 48 1993 1110 1111
13. Scheule AM Jurmann MJ Wendel HP Anaphylactic shock after aprotinin reexposure: Time course of aprotininspecific antibodies Ann Thorac Surg 63 1997 242 244
14. Package insert. Trasylol (aprotinin). Etobicoke, Ontario, Canada 1993
15. Dietrich W Spath P Ebell A Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations J Thorac Cardiovasc Surg 113 1997 194 201
16. Feindt PR Walcher S Volkmer I Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting Ann Thorac Surg 60 1995 1076 1080
17. D'Ambra MN Akins CW Blackstone EH Aprotinin in primary valve replacement and reconstruction: A multicenter, double-blind, placebo-controlled trial J Thorac Cardiovasc Surg 112 1996 1081 1089
18. Lemmer JH Jr Stanford W Bonney SL Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function Ann Thorac Surg 59 1995 132 136
19. Royston D Bidstrup BP Taylor KM Effect of aprotinin on need for blood transfusion after repeat open-heart surgery Lancet 2 1987 1289 1291
20. Dietrich W Barankay A Dilthey G Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application: Clinical experience in 152 cardiac surgical patients Thorac Cardiovasc Surg 37 1989 92 98
21. Lemmer JH Jr Dilling EW Morton JR Aprotinin for primary coronary artery bypass grafting: A multicenter trial of three dose regimens Ann Thorac Surg 62 1996 1659 1667
22. Laub GW Ricbman JB Chen C The impact of aprotinin on coronary artery bypass graft patency Chest 106 1994 1370 1375
23. Cosgrove DM III Heric B Lytle BW Aprotinin therapy for reoperative myocardial revascularization: A placebocontrolled study Ann Thorac Surg 54 1992 1031 1036
24. Swart MJ Gordon PC Hayse-Gregson PB High-dose aprotinin in cardiac surgery: A prospective, randomized study Anaesth Intensive Care 22 1994 529 533
25. Goldstein DJ DeRosa CM Mongero LB Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest J Thorac Cardiovasc Surg 110 1995 1615 1621
26. Sundt TM III Kouchoukos NT Saffitz JE Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest Ann Thorac Surg 55 1993 1418 1424
27. Hunt BJ Segal H Yacoub M Aprotinin and heparin monitoring during cardiopulmonary bypass Circulation 86 suppl 5 1992 11410 11412
28. Regragui IA Bryan AJ Izzat MB Aprotinin use with hypothermic circulatory arrest for aortic valve and thoracic aortic surgery: Renal function and early survival J Heart Valve Dis 4 1995 674 677
29. Rooney SJ Pagano D Bognolo G Aprotinin in aortic surgery requiring profound hypothermia and circulatory arrest Eur J Cardiothorac Surg 11 1997 373 378
30. Umbrain V Christiaens F Camu F Intraoperative coronary thrombosis: Can aprotinin and protamine be incriminated? J Cardiothorac Vasc Anesth 8 1994 198 201
31. Bohrer H Fleischer F Lang J Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin J Cardiothorac Anesth 4 1990 222 225
32. Havel M Grabenwoger F Schneider J Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood J Thorac Cardiovasc Surg 107 1994 807 810
33. Kalangos A Tayyareci G Pretre P Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization Eur J Cardiothorac Surg 8 1994 651 656
34. Lab M Welz A Kochs M Aprotinin in elective primary bypass surgery: Graft patency and clinical efficacy Eur J Cardiothorac Surg 9 1995 206 210
35. Hayashida N Isomura T Sato T Effects of minimal-dose aprotinin on coronary artery bypass grafting J Cardiovasc Surg 114 1997 261 269
36. Lemmer JH Jr Stanford W Bonney SL Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study J Thorac Cardiovasc Surg 107 1994 543 551
37. Bidstrup BP Underwood SR Sapsford RN Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency J Thorac Cardiovasc Surg 105 1993 147 152
38. van der Meer J Hillege HL Ascoop CA Aprotinin in aortocoronary bypass surgery: Increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study Thromb Haemost 75 1996 1 3
39. Levy JH Pifarre R Schaff HV A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting Circulation 92 1995 2236 2244
40. Hayashi J Kumon K Takanashi S Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: A double-blind, multicenter trial in Japan Transfusion 34 1994 142 146
41. Smith PK Muhlbaier LH Robinson KS Aprotinin: Safe and effective only with the full-dose regimen Ann Thorac Surg 62 1996 1575 1577
42. Murkin JM Shannon NA Bourne RB Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty Anesth Analg 80 1995 343 348
43. Janssens M Joris J David JL High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery Anesthesiology 8 1994 23 29
44. Hayes A Murphy DB McCarroll M The efficacy of single-dose aprotinin 2 million KIU in reducing blood loss and its impact on the incidence of deep venous thrombosis in patients undergoing total hip replacement surgery Anesthesiology 8 1996 357 360
45. (abstr) Haas S Muller-Esterl W Fritsche H Effect of aprotinin on the incidence of thrombosis and postoperative bleeding Thromb Haemost 54 1985 99
46. Coleman RW Hirsh J Marder VJ ed 3 Hemostasis and Thrombosis: Basis Principles and Clinical Practice 1994 Lippincott Philadelphia, PA 337
47. Seymour BD Rubinger M Rhabdomyolysis induced by epsilon-aminocaproic acid Ann Pharmacother 31 1997 56 58
48. Hoffman EP Koo AH Cerebral thrombosis associated with Amicar therapy Radiology 131 1979 687 689
49. Tsementzis SA Honan WP Nightingale S Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid Acta Neurochir 103 1990 116 121
50. Gelmers HJ Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid Acta Neurochir 52 1980 45 50
51. Tubbs RR Benjamin SP Dohn DE Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis: Case report J Neurosurg 51 1979 94 97
52. Gralnick HR Greipp P Thrombosis with epsilon aminocaproic acid therapy Am J Clin Pathol 34 1971 151 154
53. Schultz M van der Lelie H Microscopic haematuria as a relative contraindication for tranexamic acid Br J Haematol 89 1995 663 664
54. Dentz ME Slaughter TF Mark JB Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid Anesthesiology 82 1995 583 586
55. Dryden PJ O'Connor JP Jamieson WRE Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery Can J Anesth 44 1997 934 941
56. Cousin MT Boughenou F MadiJebara S Emploi des antifibrinolytiques en chirurgie cardiaque. Trois etudes prospectives. (Use of antifibrinolytics in cardiac surgery: Three prospective studies) Cahiers d'Anesthesiologie 41 1993 473 484
57. Shore-Lesserson L Reich DL Vela-Cantos F Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery Anesth Analg 83 1996 18 26
58. Corbeau JJ Monrigal JP Jacob JP Comparaison des effets de l'aprotinine et de l'acide tranexamique sur le saignement en chirurgie cardiaque. (Comparative effects of aprotinin and tranexamic acid on blood loss in cardiac surgery) Annales Francaises d'Anesthesie et de Reanimation 14 1995 154 161
59. Katsoros D Petricevic M Snow NJ Tranexamic acid reduces postbypass blood use: A double-blind, prospective, randomized study of 210 patients Ann Thorac Surg 1996 61 1996 1131 1135
60. Horrow JC Van Riper DF Strong MD The dose-response relationship of tranexamic acid Anesthesiology 82 1995 383 392
61. Speekenbrink RG Vonk AB Wildevuur CR Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting Ann Thorac Surg 59 1995 438 442
62. Blauhut B Harringer W Bettelheim P Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass J Thorac Cardiovasc Surg 108 1994 1083 1091
63. Karski JM Teasdale SJ Normann P Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid J Thorac Cardiovasc Surg 110 1995 835 842
64. Horrow JC Van Riper DF Strong MD Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery Circulation 84 1991 2063 2070
65. Ovrum E Holen EA Abdelnoor M Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations J Thorac Cardiovasc Surg 105 1993 78 83
66. Lu H Du Buit C Soria J Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy Thromb Haemost 72 1994 438 443
67. Daily PO Lamphere JA Dembitsky WP Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting: A randomized, prospective, double-blind study J Thorac Cardiovasc Surg 108 1994 99 106
68. Vander Salm^TJ Ansell JE Okike ON The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: A double-blind randomized study J Thorac Cardiovasc Surg 95 1988 538 540
69. Vander Salm TJ Kaur S Lancey RA Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid J Thorac Cardiovasc Surg 112 1996 1098 1107
70. DelRossi AJ Cernaianu AC Botros S Prophylactic treatment of postperfusion bleeding using EACA Chest 96 1989 27 30
71. Hiippala S Strid L Wennerstrand M Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty Br J Anaesth 1 1995 534 537
72. Hiippala ST Strid LJ Wennerstrand MI Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty Anesth Analg 84 1997 839 844
73. Benoni G Fredin H Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: A prospective, randomised, double-blind study of 86 patients J Bone Joint Surg Br 78 1996 434 440
74. Boylan JF Klinck JR Sandler AN Glynn MFX. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary othotopic liver transplantation Anesthesiology 85 1996 1043 1048
75. (abstr) Boylan JF Sandler AN Nierenberg H Reduced perioperative blood loss in orthotopic liver transplantation with tranexamic acid prophylaxis Can J Anaesth 39 1992 A11
76. Yassen K Bellamy MC Sadek SA Tranexamic acid reduces blood loss during orthotopic liver transplantation Clin Transplant 7 1993 453 458
77. Von Kaulla KN Kaye H Von Kaulla E Changes in blood coagulation before and after hepatectomy or transplantation in dogs and man Arch Surg 92 1966 71 79
78. Kang Y Lewis JH Navalgund A Epsilonaminocaproic acid for treatment of fibrinolysis during liver transplantation Anesthesiology 66 1987 766 773
79. Sack E Spaet TH Gentile R Reduction of prostatectomy bleeding by epsilon-aminocaproic acid N Engl J Med 266 1962 541 543
80. Andersson L Antifibrinolytic treatment with epsilonaminocaproic acid in connection with prostatectomy Acta Chir Scand 127 1964 552 564
81. Vinnicombe J Shuttleworth KE Aminocaproic acid in the control of haemorrhage after prostatectomy: Safety of aminocaproic acid—A controlled trial Lancet 1 1966 232 234
82. (letter) Naeye RL DIC case report Blood 19 1962 694
83. Ward MG Richards B Complications of antifibrinolysis therapy after prostatectomy Br J Urol 51 1979 211 212
84. Lawrence AC Ward-McQuaid JN The effect of epsilon aminocaproic acid on the blood loss after retropubic prostatectomy Br J Urol 38 1966 308 310
85. Gordon-Smith IC Hickman JA el-Masri SH The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy Br J Surg 59 1972 522 524
86. Sinclair J Forbes CD Prentice CR The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA) Urol Res 4 1976 129 131
87. Nicolaides AN Field ES Kakkar VV Prostatectomy and deep-vein thrombosis Br J Surg 59 1972 487 488
88. Leibovitch I Foster RS Wass JL Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma J Urol 153 1995 1866 1869
89. Cisek LJ Walsh PC Thromboembolic complications following radical retropubic prostatectomy: Influence of external sequential pneumatic compression devices Urology 42 1993 406 408
90. Salzman EW Weinstein MJ Weintraub RM Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: A double-blind randomized trial N Engl J Med 314 1986 1402 1406
91. Cattaneo M Harris AS Stromberg U The effect of desmopressin on reducing blood loss in cardiac surgery: A meta-analysis of double-blind, placebo-controlled trials Thromb Haemost 74 1995 1064 1070
92. D'Alauro FS Johns RA Hypotension related to desmopressin administration following cardiopulmonary bypass Anesthesiology 69 1988 962 963
93. Fleming NW Burke TA Infusion rate and hemodynamics with desmopressin J Cardiothorac Anesth 3 1989 813 815
94. Czer LS Bateman TM Gray RJ Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressin J Am Coll Cardiol 9 1987 1139 1147
95. Temeck BK Bachenheimer LC Katz NM Desmopressin acetate in cardiac surgery: A double-blind randomized study South Med J 87 1994 611 615
96. Dilthey G Dietrich W Spannagl M Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin J Cardiothorac Vasc Anesth 7 1993 425 430
97. Reich DL Hammerschlag BC Rand JH Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures J Cardiothorac Vasc Anesth 5 1991 142 145
98. Salmenpera M Kuitunen A Hynynen M Hemodynamic responses to desmopressin acetate after CABG: A doubleblind trial J Cardiothorac Vasc Anesth 5 1991 146 149
99. Jahr JS Marquez J Cottington E Hemodynamic performance and histamine levels after desmopressin acetate administration following cardiopulmonary bypass in adult patients J Cardiothorac Vasc Anesth 5 1991 139 141
100. Spyt TJ Weerasena NA Bain WH The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: A randomized, double-blind trial Perfusion 5 1990 57 61
101. Karnezis TA Stulberg SD Wixson RL The hemostatic effects of desmopressin on patients who had total joint arthroplasty: A double-blind randomized trial J Bone Joint Surg Am 76 1994 1545 1550
102. Kobrinsky NL Letts RM Patel LR 1-Desamino-8-D-arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery: A randomized, double-blinded, controlled trial Ann Intern Med 107 1987 446 450
103. Byrnes JJ Larcada A Moake JL Thrombosis following desmopressin for uremic bleeding Am J Hematol 28 1988 63 65
104. (letter) Bond L Bevan D Myocardial infarction in a patient with hemophilia treated with DDAVP N Engl J Med 318 1988 121
105. Hartmann S Reinhart W Fatal complication of desmopressin Lancet 345 1995 1302 1303
106. (letter) Cattaneo M Mannucci PM Desmopressin and blood loss after cardiac surgery Lancet 342 1993 812
107. Brown MR Swygert TH Whitten CW Desmopressin acetate following cardiopulmonary bypass: Evaluation of coagulation parameters J Cardiothorac Anesth 3 1989 726 729
108. Hedderich GS Petsikas DJ Cooper BA Desmopressin acetate in uncomplicated coronary artery bypass surgery: A prospective randomized clinical trial Can J Surg 33 1990 33 36
109. Rocha E Hidalgo F Llorens R Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery Circulation 90 1994 921 927
110. Clagett GP Valentine RJ Myers SI Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double-blind study J Vasc Surg 22 1995 223 230
111. Lethagen S Rugarn P Bergqvist D Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery Eur J Vasc Surg 5 1991 173 178
112. Hackmann T Gascoyne RD Naiman SC A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery N Engl J Med 321 1989 1437 1443
113. Mongan PD Hosking MP The role of desmopressin acetate in patients undergoing coronary artery bypass surgery: A controlled clinical trial with thromboelastographic risk stratification Anesthesiology 77 1992 38 46
114. Casas JI ZuazuJausoro I Mateo J Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass: A double-blind placebo-controlled study J Thorac Cardiovasc Surg 110 1995 1107 1117
115. Sheridan DP Card RT Pinilla JC Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction Can J Surg 37 1994 33 36
116. Rocha E Llorens R Paramo JA Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation 77 1988 1319 1323
117. Ansell J Klassen V Lew R Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double-blind study J Thorac Cardiovasc Surg 104 1992 117 123
118. Frankville DD Harper GB Lake CL Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass Anesthesiology 74 1991 988 996
119. Marquez J Koehler S Strelec SR Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: A prospective, blinded, randomized study J Cardiothorac Vasc Anesth 6 1992 674 676
120. de Prost D BarbierBoehm G Hazebroucq J Desmopressin has no beneficial effect on excesesive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass Thromb Haemost 68 1992 106 110
121. Schott U Sollen C Axelsson K Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran Acta Anaesthesiol Scand 39 1995 592 598
122. Flordal PA Ljungstrom KG Ekman B Effects of desmopressin on blood loss in hip arthroplasty: Controlled study in 50 patients Acta Orthop Scand 63 1992 381 385
123. Cazzola M Mercuriali F Brugnara C Use of recombinant human erythropoietin outside the setting of uremia Blood 89 1997 4248 4267
124. (suppl) Singbartl G Adverse events of erythropoietin in longterm and in acute/short-term treatment Clin Invest 72 1994 36 43
125. Muirhead N Renal disease. II. The clinical impact of recombinant human erythropoietin J R Coll Phys Lond 31 1997 125 130
126. Mann JF Hypertension and cardiovascular effects: Long-term safety and potential long-term benefits of r-HuEPO Nephrol Dial Transplant 10 suppl 2 1995 80 84
127. Sowade O Ziemer S Sowade B The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery J Lab Clin Med 129 1997 376 383
128. Faris PM Ritter MA Abels RI The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation J Bone Joint Surg Am 78-A 1996 62 72
129. Anonymous Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Canadian Orthopedic Perioperative Erythropoietin Study Group Lancet 341 1993 1227 1232
130. de Andrade JR Jove M Landon G Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients Am J Orthop 25 1996 533 542
131. Wells PS Lensing AW Davidson BL Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery: A metaanalysis Ann Intern Med 122 1995 47 53
132. Monography: EPREX (erythropoietin) 1996 Ortho Biotech North York, Ontario, Canada
133. Goodnough LT Rudnick S Price TH Inceased preoperative collection of autologous blood with recombinant human erythropoietin therapy N Engl J Med 321 1989 1163 1168
134. Goodnough LT Price TH Friedman KD A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: Dose, response, toxicity, and efficacy Transfusion 34 1994 66 71
135. Price TH Goodnough LT Vogler WR The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial Transfusion 36 1996 29 36
136. Biesma DH Kraaijenhagen RJ Marx JJ The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors Transfusion 33 1993 825 829
137. Watanabe Y Fuse K Naruse Y Subcutaneous use of erythropoietin in heart surgery Ann Thorac Surg 54 1992 479 483
138. Schmoeckel M Nollert G Mempel M Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery J Thorac Cardiovasc Surg 41 1993 364 368
139. Kulier AH Gombotz H Fuchs G Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery Anesth Analg 76 1993 102 106
140. Walpoth B Galliker B Spirig P Use of epoietin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery Semin Hematol 33 suppl 2 1997 75 76
141. Robinson KS Anderson DR Gross M Ultrasonographic screeing before hospital discharge for deep venous thrombosis after arthroplasty: The post-arthroplasty screening study: A randomized controlled trial Ann Intern Med 127 1997 439 445
142. Kanter MH van Maanen D Anders KH Preoperative autologous blood donations before elective hysterectomy JAMA 276 1996 798 801
143. Kruskall MS Glazer EE Leonard SS Utilization and effectiveness of a hospital autologous preoperative blood donor program Transfusion 26 1986 335 340
144. McVay PA Andrews A Hoag MS Moderate and severe reactions during autologous blood donations are no more frequent than during during homologous blood donations Vox Sanguinis 59 1990 70 72
145. AuBuchon JP Popovsky MA The safety of preoperative autologous blood donation in the nonhospital setting Transfusion 31 1991 513 517
146. McVay PA Andrews A Kaplan EB Donation reactions among autologous donors Transfusion 30 1990 249 252
147. Popovsky MA Whitaker B Arnold NL Severe outcomes of allogeneic and autologous blood donation: frequency and characterization Transfusion 35 1995 734 737
148. Hillyer CD Hart KK Lackey DA III Comparable safety of blood collection in “high-risk” autologous donors versus non-high-risk autologous and directed donors in a hospital setting Am J Clin Pathol 102 1994 275 277
149. Britton LW Eastlund DT Dziuban SW Predonated autologus blood use in elective cardiac surgery Ann Thorac Surg 47 1989 529 532
150. Sandrelli L Pardini A Lorusso R Impact of autologous blood predonation on a comprehensive blood conservation program Ann Throac Surg 59 1995 730 735
151. Suttorp MJ Kingma JH Vos J Determinants for early mortality in patients awaiting coronary artery bypass graft surgery: A case-control study Eur Heart J 13 1992 238 242
152. Goodmough Lt Monk TG Evolving concepts in autologous blood procurement and transfusion: Case reports of perisurgical anemia complicated by myocardial infarction Am J Med 101 1996 33S 37S
153. Messmer K Hemodilution Surg Clin North Am 55 1975 659 678
154. Anders MJ Lifeso RM Landis M Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee J Bone Joint Surg Am 78-A 1996 574 580
155. Elawad AA Jonsson S Laurell M Predonation autologous blood in hip arthroplasty Acta Orthop Scand 62 1991 218 222
156. Crosby E Ferguson D Hume HA Guidelines for red blood cell and plasma transfusion for adults and children Can Med Assoc J 156 11 suppl 1997 1 24
157. Richards C Kolins J Trindade CD Autologous transfusion-transmitted Yersinia enterocolitica JAMA 268 1992 1541 1542
158. Duncan KL Ransley J Elterman M Transfusion-transmitted Serratia liquifaciens from an autologous blood unit Transfusion 34 1994 738 739
159. Haditsch M Binder L Gabriel C Yersinia enterocolitica septicemia in autologous blood transfusion Transfusion 34 1994 907 909
160. Sire JM Michelet C Mesnard R Septic shock due to Yersinia enterocolitica after autologous transfusion Clin Infect Dis 17 1993 954 955
161. Linden JV Paul B Dressler KP A report of 104 transfusion errors in New York State Transfusion 32 1992 601 606
162. Goldman M Remy-Prince S Trepanier A Autologous donation error rates in Canada Transfusion 37 1997 523 527
163. (abstr, suppl) Linden JV Autologous blood errors and incidents Transfusion 34 1994 28|S
164. Gould SA Forbes JM Controversies in transfusion medicine: Indications for autologous and allogeneic transfusion: pro Transfusion 35 1995 446 449
165. Williamson KR Taswell HF Intraoperative blood salvage: A review Transfusion 31 1991 662 675
166. Dzik WH Sherburne B Intraoperative blood salvage: Medical controversies Transfus Med Rev 4 1990 208 235
167. Linden JV Kaplan HS Murphy MT Fatal air embolism due to perioperative blood recovery Anesth Analg 84 1997 422 426
168. Griffith LD Billman GF Daily PO Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate Ann Thorac Surg 47 1989 400 406
169. Ouriel K Shortell CK Green RM Intraoperative autotransfusion in aortic surgery J Vasc Surg 18 1993 16 22
170. de Haan J Boonstra PW Monnink SH Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis Ann Thorac Surg 59 1995 901 907
171. Southern EP Huo MH Mehta JR Unwashed wound drainage blood: What are we giving our patients? Clin Orthop 320 1995 235 246
172. Vertrees RA Conti VR Lick SD Adverse effects of postoperative infusion of shed mediastinal blood Ann Thorac Surg 62 1996 717 723
173. Clements DH Sculco TP Burke SW Salvage and reinfusion of postoperative sanguineous wound drainage: A preliminary report J Bone Joint Surg Am 74 1992 646 651
174. Murray DJ Gress K Weinstein SL Coagulopathy after reinfusion of autologous scavenged red blood cells Anesth Analg 75 1992 125 129
175. Milne AA Drummond GB Paterson DA Disseminated intravascular coagulation after aortic aneurysm repair, intraoperative salvage autotransfusion, and aprotinin Lancet 344 1994 470 471
176. Tawes RL Jr DuVall TB Is the “salvaged-cell syndrome” myth or reality? Am J Surg 172 1996 172 174
177. Bull BS Bull MH The salvaged blood syndrome: A sequel to mechanochemical activation of platelets and leukocytes? Blood Cells 16 1990 5 20
178. McKie JS Herzenberg JE Coagulopathy complicating intraoperative blood salvage in a patient who had idiopathic scoliosis: A case report J Bone Joint Surg Am 79 1997 1391 1394
179. Shirvani R An evaluation of clinical aspects of postoperative autotransfusion, either alone or in conjunction with pre-operative aspirin, in cardiac surgery Br J Clin Pract 45 1991 105 108
180. Davies MJ Cronin KC Moran P Autologous blood transfusion for major vascular surgery using the Sorenson Receptal Device Anaesth Intensive Care 15 1987 282 288
181. Wollinsky KH Oethinger M Buchele M Autotransfusion: Bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis: A randomized controlled study of 40 patients Acta Orthop Scand 68 1997 225 230
182. Schwieger IM Gallagher CJ Finlayson DC Incidence of Cell-Saver contamination during cardiopulmonary bypass Ann Thorac Surg 48 1989 51 53
183. (letter) Dale RF Kipling RM Smith MF Separation of malignant cells during autotransfusion Br J Surg 75 1988 581
184. Karczewski DM Lema MJ Glaves D The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery Anesth Analg 78 1994 1131 1135
185. Edelman MJ Potter P Mahaffey KG The potential for reintroduction of tumor cells during intraoperative blood salvage: Reduction of risk with use of the RC-400 leukocyte depletion filter Urology 47 1996 179 181
186. Klimberg I Sirois R Wajsman Z Intraoperative autotransfusion in urologic oncology Arch Surg 121 1986 1326 1329
187. Hart OJ III Klimberg IW Wajsman Z Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder Surg Gynecol Obstet 168 1989 302 306
188. Fujimoto J Okamoto E Yamanaka N Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma Arch Surg 128 1993 1065 1069
189. Connor JP Morris PC Alagoz T Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix Obstet Gynecol 86 1995 373 378
190. Woda R Tetzlaff JE Upper airway oedema following autologous blood transfusion from a wound drainage system Can J Anaesth 39 1992 290 292
191. Verkuyl DA Glove powder introduced in the circulation by autotransfusion and severe cardiac failure Lancet 340 1992 550
192. McAlister FA Clark HD Wells PS Perioperative allogeneic blood transfusions do not cause adverse sequalae in cancer patients: A meta-analysis of unconfounded studies Br J Surg 85 1998 171 178
193. Duffy G Neal KR Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: A meta-analysis of published randomized and nonrandomized studies Transfus Med 6 1996 325 328
194. Chung M Steinmetz OK Gordon PH Perioperative blood transfusion and outcome after resection for colorectal carcinoma Br J Surg 80 1993 427 432
195. Vamvakas EC Perioperative blood transfusion and cancer recurrence: Meta-analysis for explanation Transfusion 35 1995 760 768
196. Vamvakas EC Moore SB Perioperative blood transfusion and colorectal cancer recurrence: A qualitative statistical overview and meta-analysis Transfusion 33 1993 754 765